Association of Trypanosoma vivax in extracellular sites with central nervous system lesions and changes in cerebrospinal fluid in experimentally infected goats
© Batista et al; licensee BioMed Central Ltd. 2011
Received: 3 November 2010
Accepted: 11 May 2011
Published: 11 May 2011
Changes in cerebrospinal fluid (CSF) and anatomical and histopathological central nervous system (CNS) lesions were evaluated, and the presence of Trypanosoma vivax in CNS tissues was investigated through PCR. Twelve adult male goats were divided into three groups (G): G1, infected with T. vivax and evaluated during the acute phase; G2, infected goats evaluated during the chronic phase; and G3, consisting of non-infected goats. Each goat from G1 and G2 was infected with 1.25 × 105 trypomastigotes. Cerebrospinal fluid (CSF) analysis and investigation of T. vivax was performed at the 15th day post-infection (dpi) in G1 goats and on the fifth day after the manifestation of nervous system infection signs in G2 goats. All goats were necropsied, and CNS fragments from G1 and G2 goats were evaluated by PCR for the determination of T. vivax. Hyperthermia, anemia and parasitemia were observed from the fifth dpi for G1 and G2, with the highest parasitemia peak between the seventh and 21st dpi. Nervous system infection signs were observed in three G2 goats between the 30th and 35th dpi. CSF analysis revealed the presence of T. vivax for G2. Meningitis and meningoencephalitis were diagnosed in G2. PCR were positive for T. vivax in all the samples tested. In conclusion, T. vivax may reach the nervous tissue resulting in immune response from the host, which is the cause of progressive clinical and pathological manifestations of the CNS in experimentally infected goats.
Trypanosomes belonging to the salivary group, represented by species associated with sleeping sickness and those responsible for causing a disease known as "nagana" in ruminant livestock, cause severe economic losses in Africa, where parasite transmission occurs through the tsetse fly, a biological vector [1–3].
The clinico-pathological signs frequently reported in most outbreaks are fever, anorexia, lethargy, anemia, progressive emaciation, a rapid decline in milk production, stillborn offspring and return to estrus. Recently, Batista et al.  described important clinico-pathological and epidemiological aspects of natural infection by T. vivax that had not yet been reported in outbreaks in cattle in the Americas. Nervous signs and histological CNS lesions have been described in naturally infected cattle in Northeastern regions of Brazil, contributing to the elucidation of some pathological aspects of the CNS disease in cattle. The central neurological nature of the disease that occurs in Africa, which is caused by trypanosomosis that is triggered by salivary trypanosomes, must also be considered as an important manifestation of the disease in the Americas .
The presence of T. vivax in the CNS parenchyma, which is associated with changes and lesions in this site as described in trypanosomosis for other trypanosomes found in saliva, has not been reported. Therefore, this study was aimed at evaluating the changes in CSF, describing the anatomical and histopathological CNS lesions, and investigating the presence of the parasite in the brain of goats experimentally infected with T. vivax at 15 and 30 days post-infection using polymerase chain reaction (PCR).
Materials and methods
Twelve male goats of undefined breeds, aged approximately one year, were used in the study, and the animals were housed in stalls at the Veterinary Hospital of the Universidade Federal Rural do Semi-Árido.
Ethical procedures were based on the Brazilian law 6638 (May 8, 1979) "Normas para Prática Didático-Científica da Vivissecção de Animais" and "Ethical Principles for Use of Experimental Animals" from Colégio Brasileiro de Experimentação Animal (COBEA), Brazil, which are in accordance with the "European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes" (Strasbourg, March 18, 1986).
T. vivax infection
Before being inoculated with T. vivax, the animals were observed for two weeks, weighed, treated with anthelmintic drugs and subjected to clinical and hematological exams. The animals were randomly selected to make up the three groups, characterized as the following: group 1 (G1), composed of four goats (nos. 1, 2, 3 and 4) infected by T. vivax, evaluated during the acute phase of the disease; group 2 (G2), made up of four infected goats (nos. 5, 6, 7 and 8) and evaluated during the chronic phase; and group 3 (G3), consisting of four goats (nos. 9, 10, 11 and 12) not infected by T. vivax.
The T. vivax strain used in the experiment was obtained from the blood of a parasitemic cow affected by natural infection during an outbreak in Paraíba state, northeastern Brazil . The blood was collected in tubes containing 1 mg/mL of ethylenediaminetetracetic acid (EDTA), mixed with 8% glycerol and frozen in liquid nitrogen (-196°C). The isolate was thawed, and each animal from G1 and G2 was inoculated intravenously with 1 mL of blood containing approximately 1.25 × 105 T.vivax trypomastigotes, estimated according to the method described earlier .
In the three groups, daily clinical exams were performed to evaluate rectal temperature, the appearance of the visible mucosa and the volume of lymph nodes measurable by external palpation, as well as the behavior and general state of the animals. In G1 and G2, parasitemia was evaluated concurrently with each clinical examination using a thick drop of blood spread on a slide and covered by a cover slip, according to the technique described earlier .
Cerebrospinal fluid (CSF) collection and analysis
CSF collections in G1 goats were performed on the 15th day post-infection (dpi). In G2 goats, CSF was collected five days after the onset of nervous system infection signs. To compare the parameters, along with collections in G1 and G2, the same procedures were carried out with the animals in G3.
CSF collection was carried out with the aid of chemical tranquilization using xylazine hydrochloride at a dose of 0.1 mg/kg of body weight administered intramuscularly, followed by mechanical restraint of the animals. Cerebrospinal fluid was obtained by puncture of the cisterna magna with 25 × 8 needles and was later transferred to glass flasks. Samples of CSF were analyzed according to previously described methodology . The appearance was evaluated by comparing the tube containing the sample with another tube filled with distilled water against a white surface. Densities were obtained by refractometry. The total cell count or cellularity was performed in a Neubauer chamber immediately after obtaining the samples in order to avoid cellular degeneration. Total protein and glucose values were determined using a commercial reagent set (Katal, Belo Horizonte, Brazil). The readings were performed via spectrophotometry using the biochemical analyzer Bio-2000 (Bioplus, Barueri, Brazil). In addition, an investigation of T. vivax was conducted in fresh CSF between a slide and coverslip by light microscopy.
To carry out the anatomical and histopathological exams, all goats from G1 and two goats from G3 were euthanized on the 15th dpi. Goats no. 5, 6, and 7 from G2 died spontaneously between the 35th and 38th dpi. The two remaining goats from G3, along with goat no. 8 from G2, which did not die spontaneously, were sacrificed on the 38th dpi.
During necropsy, after the macroscopic exam, tissue fragments were collected from the CNS and were fixed in 10% buffered formalin. After fixation, the CNS was cross-sectioned at the telencephalon (frontal, parietal, occipital and temporal cortex regions), internal capsule and basal ganglia, thalamus, mesencephalon at the corpora quadrigemina, cerebelum, cerebellar peduncles, pons, medulla oblongata and the cervical, thoracic and lumbar medullae. The fixed tissues were embedded in paraffin, cut to 5 μm thickness and stained with hematoxylin and eosin (H&E).
Samples of approximately 1 cm3 from the cerebral cortex, internal capsule and cerebellar white matter from G1, G2 and G3 animals were collected and placed in Eppendorf tubes containing 70% alcohol. The DNA preparations were subjected to a highly sensitive PCR assay specific for T. vivax standardized by Cortez et al. . This PCR method targets repeated gene sequences that encode cysteine proteases (Cathepsin L) and was carried out using the oligonucleotides Tvi2 (forward: 5' GCC ATC GCC AAG TAC CTC GCC GA 3') and DTO156 (reverse: 5' TTAGAATTCCCAGGAGTTCTTGATGATCCAGTA 3') as primers. The diagnosis was confirmed via PCR by amplifying a DNA fragment of about 177 bp (base pairs) that is also observed in the DNA of T. vivax (isolated from Pantanal), which was used as positive control. The negative controls for PCR were previously selected DNA samples from the blood of non-infected goats .
For statistical analysis, a completely randomized split plot design was used. The main plot factors were the infected groups or control and the subplot was time of infection. An analysis of variance (ANOVA) was used to detect differences between treatments, followed by the use of the Tukey's test at a 5% probability level for comparison between the means.
The goats from G2 showed markedly pale ocular, oral and preputial mucosae, an increase in lymph node volume, apathy, muscle weakness and emaciation. One goat (n. 6) had a purulent eye discharge and corneal opacity. Goats no. 6 and 8 also had dyspnea and purulent nasal mucous secretions.
Goats no. 5, 6 and 7 showed neurological disorders characterized by motor incoordination, falls, opisthotonus, nystagmus, tetany, bruxism and paddling movements on days 30, 32 and 35 post-infection (pi), respectively. The fits lasted, on average, five minutes. After this time, the animals were apparently normal and had subsequent relapses of neurological signs. Goats no. 6 and 7 had accentuated hypermetria. At the end of an average clinical course of about four days, there was worsening of the clinical status, and the animals remained in a lateral decubitus position until spontaneous death, which occurred on the 35th dpi for goat no. 5, the 36th dpi for goat no. 7 and the 38th dpi for goat number 6, whereas goat no. 8 was sacrificed along with the two remaining goats from G3, since they did not die spontaneously due to parasitemia.
Average values of physicochemical parameters in cerebrospinal fluid taken from goats from the groups experimentally infected with T.vivax and evaluated in the acute and chronic phases (G1 and G2) and from goats in the control group (G3) during the experimental period.
Total protein (g/dL)
T. vivax status
The analysis of T. vivax in CNS tissues by a specific PCR for T. vivax (TviCatL-PCR) showed the amplification of a DNA fragment of about 177 bp specific for T. vivax taken from the catalytic domain of the Cathepsin L gene, which was visualized in the cerebral cortex from a G1 animal. In two animals from G2, positive results were also observed in the cerebral cortex region and the cerebellum white matter. PCR was, however, negative for all G3 samples.
Overall, the response of the experimental infection with T. vivax in goats made it possible to demonstrate two clinical courses of the disease: the acute phase, which persisted for approximately two weeks and was characterized by increased hyperthermia and parasitemia, and the chronic phase or final stage of the disease, characterized by neurological disorders, which may be associated with the extravascular migration of the parasite.
Although T. vivax undergoes all stages of its life cycle in circulating blood, the parasite has the capacity to migrate into the tissues of a vertebrate host . Thus, the participation of the parasite in the pathogenesis of inflammatory lesions that degenerate organs, such as the heart [9, 10], testicle and epididymis  and central nervous system [4, 5], has been suggested.
CSF is a biological fluid that has an intimate relationship with the central nervous system and the meninges [6, 12]. The collection and analysis of CSF are of vital importance in African trypanosomosis, as they determine the clinical stage of the disease and guide the treatment method to be used in each case [13, 14]. Any condition capable of affecting the meninges and the encephalon can produce inflammatory changes capable of raising the values of CSF constituents above the reference levels. As a general rule, infectious agents promote meningoencephalitis with pleocytosis and increases in total protein, which in turn modifies the appearance of CSF from clear to turbid and increases the density values [12, 15]. In this study, T. vivax was not observed in the CSF of G1 animals; there were also no neurological signs or significant statistical differences in the physicochemical parameters of CSF when values were compared with G3 goats. As the disease progressed and the G2 goats showed neurological disorders, important changes in CSF were observed, such as turbidity, pleocytosis, high density and increased average total protein values, as well as hypoglycorrhachia. Thus, the alterations seen in the CSF from G2 goats reflect the violation of the state of health of the CNS by T. vivax.
Hypoglycorrhachia, the reduction of glucose values in the CSF, is generally found in hypoglycemia cases, prevention of transport through the blood-brain barrier, increases in metabolism of the brain parenchyma or infections by glycolytic organisms . The CSF evaluation revealed that G2 goats showed mean CSF glucose values below the reference range for the species in addition to a significant reduction compared to values found in G1 and G3 animals [6, 12]. The reduction of serum glucose levels is an important biochemical change in cattle experimentally infected with T. vivax and is associated with energy expenditure caused by hyperthermia and with consumption of blood glucose by trypanosomes .
The clinical course of the disease and the CSF changes seen in this study are also observed in humans and closely resemble the changes described in human African trypanosomosis caused by T. brucei [2, 3]. In human African trypanosomosis, meningoencephalitis is found when cell counts exceed 5 cells/μL of CSF . A similar observation was made in three G2 goats that had an average count of 25 cells/μL of CSF, coinciding with the diagnosis of meningoencephalitis subsequently proven in the histological exam. The occurrence of neurological signs associated with the presence of trypanosomes in the CSF of three G2 goats, as well as the inflammatory lesions characterized by meningoencephalitis, demonstrate the importance of T. vivax as the cause for clinical and pathologic manifestations of the CNS. Neurological complications associated with experimental infection by T. vivax were also observed by Whitelaw et al. , who found T. vivax in the CSF of goats that presented nervous system signs and meningoencephalitis.
The evaluation of goats experimentally infected with T. vivax isolates obtained during a cattle outbreak confirmed the tropism of T. vivax for the CNS. Cattle naturally infected in the outbreak mentioned above showed nervous signs characterized by incoordination, muscle tremors, opisthotonus, and hypermetria. In these animals, meningoencephalitis and malacia of the cerebellar white matter, thalamus and basal ganglia were observed . The locations of brain lesions described in the goats in this study, which were more severe in the brainstem, cerebellum and meninges, were remarkably similar to those described in humans infected by T. brucei gambiense . The clinical signs of ataxia and incoordination in the animals from G2 were consistent with cerebellar and brainstem lesions. In East African endemic areas, the rate development of nervous system signs in trypanosomosis caused by T. brucei rhodesiense is about 18% and generally corresponds to a diffuse meningoencephalitis with a predominance of lesions at the base of the brain .
The technique of DNA extraction for subsequent implementation of polymerase chain reaction (PCR), which is sensitive and specific in the detection of T. vivax in parasitized animals, has been refined so that not only blood , but also tissues  can be used as samples for research on the parasite. This technique has been widely employed in molecular studies because of the relative ease with which it can amplify specific in vitro regions of the genome of any organism. PCR enables the amplification of DNA sequences that are present in complex mixtures and enables a variety of studies of different natures, such as the development of highly sensitive and specific diagnosis methods, obtaining large quantities of DNA for sequencing and analyses of genetic diversity of populations.
The extravascular location of T. vivax plays an important role in the clarification of the pathogenesis of lesions in several systems. It is therefore notable that T. vivax was detected by PCR in CNS tissues for the first time, such that the parasite may be directly associated with lesions in these sites, contributing to the appearance of histopathological lesions and, consequently, to the appearance of nervous system infection signs. It is important to highlight the presence of T. vivax in the CNS parenchyma identified by the PCR technique in a goat from G1. This observation suggests early invasion of the CNS by the parasite, regardless of the physicochemical changes in CSF or manifestations of neurological disorders. In this way, CNS invasion by trypanosomes can be early in the infection process and may coincide with their presence in the circulation (hemolymphatic stage) . Positive PCR results in nervous system areas indicate that as the disease progressed, the animals showed severe histological lesions. Therefore, the relationship between the nervous system lesions and the presence of the parasite in this site is clear.
The etiopathogenic mechanisms of CNS lesions caused by several trypanosome species remain under investigation. Some authors suggest that the lesions occur due to circulatory changes caused by emboli formed by trypanosomes, leukocytes and fibrin in capillaries and venules in the brain . The immune-mediated reactions are involved in the pathogenesis of lesions, as anti-CNS antibodies are described in the CSF in infections by trypanosomes . Stiles et al.  identified and characterized a peptide derived from T. brucei that induces apoptosis of vascular endothelial cells in the brain and cerebellum. Recently, Masocha et al.  conducted an experiment on the migration of T. brucei through the blood-brain barrier of rodents and concluded that while the basal membrane composition of intracerebral vessels determines the site of parasite penetration in the brain, γ-interferon is involved in the immunological control of infection, facilitating the penetration of T. brucei through the basal membrane of the blood-brain barrier.
In conclusion, T. vivax may reach the nervous tissue resulting in immune response from the host, which is the cause of progressive clinical and pathological manifestations of CNS in experimentally infected goats.
- Dumas M, Bouteille B: Human African trypanosomiasis. C R Seances Soc Biol Fil. 1996, 190: 395-408. (in French)PubMed
- Checkley AM, Pepin J, Gibson WC, Taylor MN, Jäger HR, Mabey DC: Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy. Trans R Soc Trop Med Hyg. 2007, 101: 523-526. 10.1016/j.trstmh.2006.12.001.View ArticlePubMed
- Lejon V, Buscher P: Review article: cerebrospinal fluid in human african trypanosomiasis: a key to diagnosis, therapeutic decision e post-treatment follow-up. Trop Med Int Health. 2005, 10: 395-403. 10.1111/j.1365-3156.2005.01403.x.View ArticlePubMed
- Batista JS, Riet-Correa F, Teixeira MMG, Madruga CR, Simões SVD, Maia F: Trypanosomiasis by Trypanosoma vivax in cattle in the Brazilian semiarid: description of an outbreak and lesions in the nervous system. Vet Parasitol. 2007, 143: 174-181. 10.1016/j.vetpar.2006.08.017.View ArticlePubMed
- Batista JS, Bezerra FSB, Lira RA, Carvalho JRG, Rosado Neto AM, Petri AA, Teixeira MMG: Aspectos clínicos, epidemiológicos e patológicos da infecção natural em bovinos por Trypanosoma vivax na Paraíba. Pesq Vet Bras. 2008, 28: 63-69. 10.1590/S0100-736X2008000100010. (in Portuguese)View Article
- Scott PR: Analysis of cerebrospinal fluid from field cases of some common ovine neurological diseases. Br Vet J. 1992, 148: 15-22.View ArticlePubMed
- Cortez AP, Rodrigues AC, Garcia HA, Neves L, Batista JS, Bengaly Z, Paiva F, Teixeira MMG: Cathepsin L-like genes of Trypanosoma vivax from Africa and South America: characterization, relationships and diagnostic implications. Mol Cell Probes. 2009, 23: 44-51. 10.1016/j.mcp.2008.11.003.View ArticlePubMed
- Gardiner PR, Assoku RK, Whitelaw DD, Murray M: Haemorrhagic lesions resulting from Trypanosoma vivax infection in Ayrshire cattle. Vet Parasitol. 1989, 34: 187-189.View Article
- Masake RA: The pathogenesis of infection with Trypanosoma vivax in goats and cattle. Vet Rec. 1980, 13: 551-557.
- Kimeto BA, Mugera GM, Nyaga PN: Haemorrhagic pancarditis in cattle infected with Trypanosoma vivax. Vet Parasitol. 1990, 34: 295-301. 10.1016/0304-4017(90)90076-N.View ArticlePubMed
- Batista JS, Oliveira AF, Rodrigues CMF, Damasceno CAR, Oliveira IRS, Alves HM, Paiva ES, Brito PD, Medeiros JMF, Rodrigues AC, Teixeira MMG: Infection by Trypanosoma vivax in goats and sheep in the Brazilian semiarid region: from acute disease outbreak to chronic cryptic infection. Vet Parasitol. 2009, 165: 131-135. 10.1016/j.vetpar.2009.07.005.View ArticlePubMed
- Doyle C, Solano-Gallego L: Cytologic interpretation of canine cerebrospinal fluid samples with low total nucleated cell concentration, with and without blood contamination. Vet Clin Pathol. 2009, 38: 392-396. 10.1111/j.1939-165X.2009.00132.x.View ArticlePubMed
- Bisser S, Lejon V, Preux PM, Bouteille B, Stanghellini A, Jauberteau MO, Büscher P, Dumas M: Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci. 2002, 193: 127-135. 10.1016/S0022-510X(01)00655-4.View ArticlePubMed
- Kennedy PGE: Human African trypanosomiasis neurological aspects. J Neurol. 2006, 253: 411-416. 10.1007/s00415-006-0093-3.View ArticlePubMed
- Stokol T, Divers TJ, Arrigan JW, McDonough SP: Cerebrospinal fluid findings in cattle with central nervous system disorders: a retrospective study of 102 cases (1990-2008). Vet Clin Pathol. 2009, 38: 103-112. 10.1111/j.1939-165X.2008.00094.x.View ArticlePubMed
- Kadima KB, Gyang EO, Saror DI, Esievo KAN: Serum biochemical values of Trypanosoma vivax infected cattle and effects of lactose in saline infusion. Vet Arch. 2000, 70: 67-74.
- Kennedy PGE: Diagnosing central nervous system trypanosomiasis: two stage or not to stage?. R Soc Trop Med Hyg. 2008, 102: 306-307. 10.1016/j.trstmh.2007.11.011.View Article
- Whitelaw DD, Gardiner PR, Murray M: Extravascular foci of Trypanosoma vivax in goats: the central nervous system and aqueous humor of the eye as potential sources of relapse infections after chemotherapy. Parasitology. 1988, 97: 51-61. 10.1017/S0031182000066737.View ArticlePubMed
- Ventura RM, Paiva F, Silva RAMS, Takeda GF, Buck GA, Teixeira MMG: Trypanosoma vivax: characterization of the spliced-leader gene for a Brazilian stock and species-specific detection by PCR amplification of an intergenic space sequence. Exp Parasitol. 2001, 99: 37-48. 10.1006/expr.2001.4641.View ArticlePubMed
- Rodgers J: Human African trypanosomiasis chemotherapy and CNS disease. J Neuroimmunol. 2009, 211: 16-22. 10.1016/j.jneuroim.2009.02.007.View ArticlePubMed
- Losos GJ, Ikede BO: Review of pathology of diseases in domestic and laboratory animals caused by Trypanosoma congolense, T. vivax, T. rhodesiense and T. gambiense. Vet Pathol. 1972, 9: 1-71.View Article
- Stiles JK, Whittaker J, Sarfo YB, Thompson WE, Powell MD, Bond VC: Trypanosome apoptotic factor mediates apoptosis in human brain vascular endothelial cells. Mol Biochem Parasitol. 2004, 133: 229-240. 10.1016/j.molbiopara.2003.10.011.View ArticlePubMed
- Masocha W, Rottenberg ME, Kristensson K: Migration of African trypanosomes across the blood-brain barrier. Physiol Behav. 2007, 92: 110-114. 10.1016/j.physbeh.2007.05.045.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.